A clinical conundrum: to measure or not measure direct oral anticoagulants before a surgery or procedure?
The management of patients who are receiving a direct oral anticoagulant (DOAC) and require a surgery or an invasive procedure is a common clinical problem, with 500,000–750,000 such patients being assessed annually in North America and Europe alone, and is pertinent to a wide array of clinicians that includes internists, surgeons and anaesthetists [1, 2]. The future scope of this problem is likely to increase as more patients receive a DOAC instead of a vitamin K antagonist (VKA) for the management of atrial fibrillation and venous thromboembolism especially in an ageing population, as elderly patients are most likely to require a surgery or invasive procedure .
The overall perioperative management of patients who are receiving an anticoagulant has shifted away from bridging with a low-molecular-weight heparin during anticoagulant interruption, given recent evidence that heparin bridging results in more bleeds without a reduction in thromboembolism whether patients are receiving...
Compliance with ethical standards
Conflict of interest
The authors declare that they have no conflict of interest.
Statement of human and animal rights
This article does not contain any studies with human participants or animals performed by any of the authors.
- 14.Tripodi A et al (2017) Position Paper on laboratory testing for patients on direct oral anticoagulants. A Consensus Document from the SISET, FCSA, SIBioC and SIPMeL. Blood Transfus 13:1–9Google Scholar